IFNB1 and COVID-19: This includes “CXCR chemokine receptor binding,” “IFNA response,” “IFNB1 targets,” “Upregulated in beta interferon treated bronchial epithelial cells,” “Upregulated in COVID19 bronchial epithelial cells,” “Upregulated in COVID19 SARS-CoV-2 infection CALU3 cells,” and “Upregulated in human parainfluenza virus 3 infection A594 cells.” These positively regulated terms are mainly related to the immune system or represent groups of genes noted to be affected after viral infections.